Dermatology Doctors in Prince Frederick, MD Accepting Medicare

4 Dermatology doctors found. Showing 1 - 4

Alvanus Howland Hartley, MD Dermatology Medicare: Accepting Medicare Assignments Practice Location: 995 Prince Frederick Blvd, Suite 204, Prince Frederick, MD 20678 Phone: 410-535-5855    Fax: 410-535-6574

Dr. Faris Hawit, M.D. Dermatology Medicare: Accepting Medicare Assignments Practice Location: 130 Hospital Rd, Ste 200, Prince Frederick, MD 20678 Phone: 410-535-4561

Mary Miller Braden, MD Dermatology Medicare: Accepting Medicare Assignments Practice Location: 995 Prince Frederick Blvd Ste 204, Prince Frederick, MD 20678 Phone: 443-351-3376    Fax: 410-535-6574

Dr. Brian Michael Connolly, MD Dermatology Medicare: Accepting Medicare Assignments Practice Location: 995 Prince Frederick Blvd Ste 204, Prince Frederick, MD 20678 Phone: 443-351-3376

News Archive

Persistent use of ecstasy leads to a loss of everyday memory

Persistent use of ecstasy leads to a loss of everyday memory, researchers from Northumbria University have discovered. For the study 23 regular users of ecstasy were compared to 30 people who had never used the drug.

Study shows increasing size of respiratory droplets under cold humid conditions

Considerable evidence has accumulated to suggest that the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) virus may spread through prolonged or brief contact with infected patients - with the infection being spread through respiratory droplets and aerosols. The need to understand how these infectious droplets behave becomes ever more urgent. A recent study published in the preprint server medRxiv* in October 2020 reports the results of such an investigation.

NUHW files for union election, but refuses to sign agreement

Two weeks after filing for a union election among 46,000 Kaiser workers in California, the National Union of Healthcare Workers (NUHW) refused to sign an agreement that would allow the election to go forward in the next 60 days.

Novel combination of cancer drugs can have therapeutic impact on diffuse large B-cell lymphoma

New research from Roswell Park Cancer Institute shows that promising cancer drugs used in combination can have significant therapeutic impact on a particularly aggressive subtype of diffuse large B-cell lymphoma (DH-DLBCL) in preclinical studies. The researchers will present their findings at the American Association for Cancer Research (AACR) Annual Meeting 2016, to be held April 16-20 in New Orleans.

Read more Medical News

› Verified 9 days ago